BioNexus Gene Lab Corp. Effect of Exchange Rate on Cash
BioNexus Gene Lab Corp. (BGLC) reported Effect of Exchange Rate on Cash of $60.89 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-30.
Discontinued › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCash · last filed 2021-03-30
- BioNexus Gene Lab Corp. effect of exchange rate on cash for fiscal 2020 was $60.89K, a 525.70% increase from fiscal 2019.
- BioNexus Gene Lab Corp. effect of exchange rate on cash for fiscal 2019 was $9.73K.
| Period end | Effect of Exchange Rate on Cash 12 month |
|---|---|
| 2020-12-31 | $60.89K 10-K · filed 2021-03-30 |
| 2019-12-31 | $9.73K 10-K · filed 2021-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |